Pharmaceutical Industry

Page 86 of 100

Bill Ackman
Health

Valeant, Ackman Must Face U.S. Insider Trading Lawsuit

By
November 11, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant CEO Defends Firm but Says He Doesn’t Have ‘Full Knowledge’

By
November 10, 2015
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Health

Astrazeneca is Buying ZS Pharma for $2.7 billion

By
November 6, 2015
Walgreens-Rite Aid deal could lead to elimination of 3,000 stores
Retail

Walgreens-Rite Aid deal could lead to elimination of 3,000 stores

By
November 5, 2015
MSMB Capital Management CIO Martin Shkreli
Health

Turing Says it Will Lower Daraprim Price by the End of the Year

By
November 4, 2015
Fortune Global Forum 2015
Health

How the U.S. Subsidizes Europe’s Health Care Costs

By
November 3, 2015
Hedge fund manager Bill Ackman
Finance

Bill Ackman on Valeant: ‘Life will go on’

By
October 30, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health

Valeant cuts ties to controversial pharmacy chain Philidor

By
October 30, 2015
Hedge fund manager Bill Ackman
Finance

Another one of Bill Ackman’s top stocks is down 50%

By
October 29, 2015
A Starbucks cafe in Sanlitun. For the third quarter of 2015
Features

Pharma megadeal and Starbucks earnings — 5 things to know today

By Tom Huddleston Jr. and Geoffrey Smith
October 29, 2015
Allergan Inc.'s Botox Cosmetic As Actavis Plc Buys Drugmaker For $66 Billion
Health

When Viagra met Botox: Pfizer, Allergan eye mega-merger

By
October 29, 2015
Cholesterol lowering pill
Health

This drug will make your flu shot less effective

By
October 29, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Valeant accounting scandal: 4 critical questions that have been left unanswered

By
October 26, 2015
Why the drug price scandal won’t be enough to keep down prices
Retail

Why the drug price scandal won’t be enough to keep down prices

By
October 26, 2015
Imprimis Turing Drug
Health

This company is offering a $1 alternative to Turing’s $750 drug

By
October 23, 2015

Most Popular